Dossier assessment

Empagliflozin - Benefit assessment according to §35a Social Code Book V (dossier assessment)

Status
Status: Commission completed
Project no.
A14-26
Last updated

Report documents

  1. Extract of dossier assessment

    Empagliflozin - Benefit assessment according to §35a Social Code Book V (dossier assessment)

    published on
    Document type
    PDF document, 299 kB, EN, not accessible
  2. Dossier assessment

    Empagliflozin - Benefit assessment according to §35a Social Code Book V (dossier assessment)

    published on
    Document type
    PDF document, 642 kB, DE, not accessible

Press releases

Empagliflozin in type 2 diabetes: added benefit not proven

Comparison of different treatment regimens made it impossible to clearly attribute the effect to the drug

Additional information

Federal Joint Committee (G-BA)

2015-02-05 A G-BA decision was published.

G-BA documents on this decision

Project details

Project no.
A14-26
Commission
Commission awarded on 15.08.2014 by the Federal Joint Committee (GBA).
Report type
Dossier assessment
Status
Commission completed
Department/Division
Drug Assessment
Topic
Digestion, metabolism and hormones
Note

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.

Connected Projects

  1. Dossier assessment

    Empagliflozin - Benefit assessment according to §35a Social Code Book V

    Project no.
    A16-12
    Last updated

    Status: Commission completed

  2. Addendum

    Addendum to Commission A14-26 (empagliflozin)

    Project no.
    A14-50
    Last updated

    Status: Commission completed

  3. Dossier assessment

    Empagliflozin (type 2 diabetes mellitus in children and adolescents) – Benefit assessment according to §35a Social Code Book V

    Project no.
    A23-142
    Last updated

    Status: Commission completed

  4. Dossier assessment

    Empagliflozin (renal insufficiency) - Benefit assessment according to § 35a Social Code Book V

    Project no.
    A23-78
    Last updated

    Status: Commission completed

  5. Dossier assessment

    Empagliflozin (heart failure) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A21-93
    Last updated

    Status: Commission completed

  6. Dossier assessment

    Empagliflozin (heart failure) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A22-39
    Last updated

    Status: Commission completed

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form